|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| License and other revenue | |||||
| Product revenue, net | |||||
| Total revenue | |||||
| Costs and operating expenses: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| General and administrative | |||||
| Goodwill impairment | |||||
| Gain on sale of non-financial asset | |||||
| Total operating expense | |||||
| Loss from operations | |||||
| Other income (expense), net: | |||||
| Interest income | |||||
| Interest expense | |||||
| Change in fair value of warrant liability | |||||
| Other (expense) income, net | |||||
| Total other income (expense), net | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Net loss | |||||
| Net loss per share attributable to common stockholders—basic | |||||
| Weighted average shares of common stock outstanding—basic | |||||
| Net loss per share attributable to common stockholders—diluted | |||||
| Weighted average shares of common stock outstanding—diluted | |||||
| Change in unrealized losses on marketable securities | |||||
| Supplemental Income Statement Elements | |||||
| Change in net unrealized gains on marketable debt securities | |||||
| Comprehensive loss | |||||
Loading...